ORAMED PHARMACEUTICALS INC.
Close on Oct 19, 2026
- Market cap
- $172.56M
- P/E (TTM)
- 1.0
- Dividend yield
- 6.16%
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2025 Ended Sep 30, 2025 | Oct 24, 2025 | After market close | – | – | – |
Press releases
Announcements Oramed Pharmaceuticals filed with the SEC
PRESS RELEASE DATED JANUARY 13, 2026
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JANUARY 7, 2026
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 17, 2025.
Results of operations · EX-99.1 to Form 8-K
SHAREHOLDER LETTER, DATED OCTOBER 23, 2025
Material agreement · Agreement terminated · Results of operations · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 28, 2025 (FURNISHED PURSUANT TO ITEM 7.01)
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 11, 2025 (FURNISHED PURSUANT TO ITEM 7.01)
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED OCTOBER 7, 2024
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 20, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED SEPTEMBER 21, 2023
Material agreement · Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
NOTE TERM SHEET, DATED SEPTEMBER 11, 2023 AMONG THE COMPANY, SCILEX HOLDING COMPANY, AND SORRENTO THERAPEUTICS, INC
Other events · EX-99.2 to Form 8-K
TERM SHEET DATED AUGUST 4, 2023, BY AND AMONG ORAMED PHARMACEUTICALS INC. AND SORRENTO THERAPEUTICS, INC
Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED DECEMBER 12, 2022
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 10, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 7, 2022
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JANUARY 12, 2022
Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED DECEMBER 7, 2021
Regulation FD disclosure · EX-99.1 to Form 8-K